The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Roche
Research Funding - Abbvie; Roche
Other Relationship - Roche
Fixed-duration venetoclax-obinutuzumab for previously untreated patients with chronic lymphocytic leukemia: Follow-up of efficacy and safety results from the multicenter, open-label, randomized, phase III CLL14 trial.
 
Othman Al-Sawaf
Honoraria - Abbvie; Gilead Sciences; Janssen-Cilag; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen-Cilag; Roche
Research Funding - Abbvie; BeiGene; Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen-Cilag; Roche
 
Can Zhang
No Relationships to Disclose
 
Maneesh Tandon
Employment - Roche
 
Arijit Sinha
Employment - Roche
 
Anna Maria Fink
Consulting or Advisory Role - Janssen
Research Funding - Celgene
 
Sandra Robrecht
No Relationships to Disclose
 
Eugen Tausch
Consulting or Advisory Role - Roche
Speakers' Bureau - Abbvie; Janssen-Cilag; Roche
Travel, Accommodations, Expenses - Abbvie
 
William L. Schary
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Matthias Ritgen
No Relationships to Disclose
 
Clemens Martin Wendtner
Honoraria - Abbvie; Gilead Sciences; Janssen; MorphoSys; Mundipharma; Novartis; Roche
Research Funding - Gilead Sciences; Janssen; Morphosys; Mundipharma; Novartis; Roche; Roche
 
Karl A Kreuzer
Consulting or Advisory Role - Abbvie; Roche
Expert Testimony - Abbvie; Roche
 
Barbara Eichhorst
Honoraria - Abbvie; Celgene; Janssen; Novartis; Roche
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen; Novartis; Roche
Speakers' Bureau - Abbvie; Celgene; Gilead Sciences; Janssen; Roche
Research Funding - Abbvie; Celgene; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche
 
Stephan Stilgenbauer
Honoraria - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Speakers' Bureau - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Research Funding - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen; Roche
 
Michael J. Hallek
Honoraria - Abbvie; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Abbvie; Genentech/Roche; Gilead Sciences; Janssen
Speakers' Bureau - Abbvie; Gilead Sciences; Janssen; Roche/Genentech
Research Funding - Abbvie; Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Roche
 
Kirsten Fischer
Honoraria - Abbvie
Travel, Accommodations, Expenses - Roche